LISA STEPHENS: Open Payments
NPI 1831590769 · CLEARFIELD, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 33 payments from 12 companies in 2025. Trend: 2023 $939 · 2024 $327 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $166 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Lilly USA, LLC | 4 | $66 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Lundbeck LLC | 2 | $31 |
| Astellas Pharma US Inc | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
Products named: REXULTI, VRAYLAR, UBRELVY, MOUNJARO, Sunosi, Ozempic, XIFAXAN, ZEPBOUND.
Industry payments across UT — which companies pay providers there.
